V6L-16221-82965
3 vaccinations
4 coded responses
31 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 232 / VA
- Registered
- 2021-08-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-04
Registered in v-safe
-
2021-08-04
Dose 1 — Pfizer-BioNTech
- 2021-08-04
- 2021-08-05
- 2021-08-06
-
2021-08-07
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-08
- 2021-08-09
- 2021-08-10
- 2021-08-11
- 2021-08-18
-
2021-09-08
Dose 2 — Pfizer-BioNTech
- 2021-09-08
-
2021-09-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fever · Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-09-10
- 2021-09-11
- 2021-09-12
- 2021-09-13
- 2021-09-14
- 2021-09-15
- 2021-09-22
- 2021-09-29
-
2021-10-06
Survey response — day 28, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesFree text: A cold. Not covid - tested negative via PCR testMedDRA releases: 2024-11 · check-in free text available
- 2021-10-13
- 2021-10-22
- 2021-12-10
-
2022-03-18
Dose 3 — Pfizer-BioNTech
-
2022-03-19
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
- 2022-03-20
- 2022-03-21
- 2022-03-22
-
2022-03-24
Survey response — days 1–6 daily, dose 3MedDRA: Rhinorrhoea, Sneezing — Feeling: FairFree text: Runny nose, sneezingMedDRA releases: 2024-11 · check-in free text available
- 2022-04-10
- 2022-04-29
-
2022-06-17
Survey response — 3 months, dose 3MedDRA: Ear infection, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus infection and ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-17
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-04 | Pfizer-BioNTech | No |
| 2 | 2021-09-08 | Pfizer-BioNTech | No |
| 3 | 2022-03-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-17 | Successful 2022-06-21 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): No
Release 10 — day 28, dose 2
Symptoms: A cold. Not covid - tested negative via PCR test
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Runny nose, sneezing
Release 12 — 3 months, dose 3
Symptoms: Sinus infection and ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | No adverse event | ✓ | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release